Delivery Order SPE2DB20D3103-SPE2DB22FM2V4
- Not listed
- This federal contract award issued by the Defense Logistics Agency (DLA) is a delivery order valued at $16,182.64 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a completion date of September 19, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $14,550.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TIVICAY 50 MG TABLET 30S. The contract, a Delivery Order with a Firm Fixed Price, has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a critical supplier of pharmaceutical products and medical...
- This federal contract award is for the delivery of Tivicay 50 mg tablets to the Defense Logistics Agency (DLA). The $3,637.74 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are for-profit...
- This federal contract award is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,071.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of November 17, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $82,294.68 for the supply of TIVICAY 50 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4556527701 - TIVICAY 50 MG TABLET 30S. The firm-fixed-price contract has a total ceiling value of $3,441.72 and an ultimate completion date of March 11, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) through January 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $3,637.74 firm fixed-price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant...
- This federal contract award, valued at $2,668.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $5,337.24 firm fixed price contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a completion date of June 25, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $20,167.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price contract. The award is not associated with a set-aside designation, indicating open competition....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM2V4Delivery Order
This federal contract award is for the delivery of pharmaceutical products, specifically TIVICAY 50 MG TABLET 30S, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 12, 2022, with a ceiling value of $15,958.44. The contract is a Delivery Order under a Firm Fixed Price pricing type, with an ultimate completion date of January 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract award does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 1/12/22 |